EcoDrugPlus

Potassium Voltage-Gated Channel, Kqt-Like Subfamily, Member 2a

Ensembl ID : ENSPFOG00000009098
Gene Symbol: KCNQ2A
1 Cross references
185 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSPFOG00000018161
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSPFOG00000006904
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Presenilin-1

Ensembl ID : ENSPFOG00000023620
Gene Symbol: LOC103150041
3 Cross references
200 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPFOG00000005786
Gene Symbol: LOC103146042
3 Cross references
250 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPFOG00000002899
Gene Symbol: LOC103153388
3 Cross references
255 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSPFOG00000002202
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPFOG00000015247
Gene Symbol: PTGDR2
1 Cross references
145 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPFOG00000019947
Gene Symbol: PTGDR2
4 Cross references
135 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSPFOG00000022309
Gene Symbol: PTGER1A
1 Cross references
165 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSPFOG00000023602
Gene Symbol: PTGER3
1 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSPFOG00000007304
Gene Symbol: PTGER4A
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).